Phencyclidine/Schizophrenia: One View Toward the Past, The Other to the Future

被引:56
作者
Domino, Edward F. [1 ]
Luby, Elliot D. [2 ,3 ]
机构
[1] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA
[2] Wayne State Univ, Dept Psychiat & Behav Sci, Detroit, MI USA
[3] Comprehens Psychiat Serv, Farmington Hills, MI USA
关键词
phencyclidine; drug model; drug of abuse; MESSENGER-RNA EXPRESSION; PREFRONTAL CORTEX; RECEPTOR-BINDING; DOPAMINE HYPOTHESIS; THOUGHT-DISORDER; NMDA ANTAGONIST; SCHIZOPHRENIA; PHENCYCLIDINE; KETAMINE; NEURONS;
D O I
10.1093/schbul/sbs011
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
The history of the chemical synthesis and animal/human pharmacology of phencyclidine is documented. From its early use as a general anesthetic, chemical model of schizophrenia, and drug of abuse, phencyclidine has had a checkered history. Research with this agent and its chemical derivatives like ketamine have provided a solid foundation for just a beginning to understanding the neuropathology of schizophrenia.
引用
收藏
页码:914 / 919
页数:6
相关论文
共 44 条
[12]  
Domino EF, 1981, PHENCYCLIDINE HIST C
[13]  
DOMINO EF, 1981, PCP PHENCYCLIDINE HI, P401
[14]   The emerging role of glutamate in the pathophysiology and treatment of schizophrenia [J].
Goff, DC ;
Coyle, JT .
AMERICAN JOURNAL OF PSYCHIATRY, 2001, 158 (09) :1367-1377
[15]  
GREIFENSTEIN F E, 1958, Anesth Analg, V37, P283
[16]  
Hashimoto T, 2003, J NEUROSCI, V23, P6315
[17]  
JAVITT DC, 1991, AM J PSYCHIAT, V148, P1301
[18]   The neuropsychopharmacology of phencyclidine: From NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia [J].
Jentsch, JD ;
Roth, RH .
NEUROPSYCHOPHARMACOLOGY, 1999, 20 (03) :201-225
[19]   SUBANESTHETIC EFFECTS OF THE NONCOMPETITIVE NMDA ANTAGONIST, KETAMINE, IN HUMANS - PSYCHOTOMIMETIC, PERCEPTUAL, COGNITIVE, AND NEUROENDOCRINE RESPONSES [J].
KRYSTAL, JH ;
KARPER, LP ;
SEIBYL, JP ;
FREEMAN, GK ;
DELANEY, R ;
BREMNER, JD ;
HENINGER, GR ;
BOWERS, MB ;
CHARNEY, DS .
ARCHIVES OF GENERAL PSYCHIATRY, 1994, 51 (03) :199-214
[20]   Effects of ketamine in normal and schizophrenic volunteers [J].
Lahti, AC ;
Weiler, MA ;
Michaelidis, T ;
Parwani, A ;
Tamminga, CA .
NEUROPSYCHOPHARMACOLOGY, 2001, 25 (04) :455-467